NIH VideoCast - TRACO 2017 - Ovarian Cancer in the Genomics Era and Immune checkpoints

Skip Navigation

TRACO 2017 - Ovarian Cancer in the Genomics Era and Immune checkpoints

Loading... Loading video...

201 Views

Air date:	Monday, September 25, 2017, 4:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 201 (26 Live, 175 On-demand)
Category:	TRACO
Runtime:	01:50:04
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Translational Research in Clinical Oncology (TRACO) Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics. For more information go to http://ccr.cancer.gov/trainee-resources-courses-workshops-traco

NLM Title:	TRACO 2017. Ovarian cancer in the genomics era and immune checkpoints / Christina M. Annunziata, MD, PhD, NCI, NIH and Stephanie L. Goff, M.D., NCI, NIH.
Author:	Annunziata, C. Goff, S. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): Translational Research in Clinical Oncology (TRACO) Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in developing and implementing many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics.
Subjects:	Ovarian Neoplasms--genetics Ovarian Neoplasms--immunology
Publication Types:	Lecture Webcast

NLM Classification:	WP 322
NLM ID:	101713969
CIT Live ID:	24980
Permanent link:	https://videocast.nih.gov/watch=24980